(Q38100206)

28 August 2017

Novel therapeutic targets for nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

28 August 2017

1 reference

Akiko Eguchi

1

1 reference

28 August 2017

Davide Povero

series ordinal

2

1 reference

28 August 2017

Naim Alkhouri

series ordinal

3

1 reference

28 August 2017

Ariel E Feldstein

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

22 April 2013

1 reference

Expert Opinion on Therapeutic Targets

28 August 2017

1 reference

28 August 2017

17

1 reference

28 August 2017

7

1 reference

28 August 2017

773-779

1 reference

Nonalcoholic fatty liver disease

28 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Nonalcoholic fatty liver disease in the pediatric population: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Nonalcoholic fatty liver disease: current issues and novel treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Novel insights into the pathophysiology of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Microparticles: major transport vehicles for distinct microRNAs in circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Transfer of microRNAs by embryonic stem cell microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Microparticles, vascular function, and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Inflammasomes in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Toll-like receptors: critical proteins linking innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Toll-like receptors and adaptor molecules in liver disease: update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Therapeutic approach to regulate innate immune response by Toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Incretin and islet hormonal responses to fat and protein ingestion in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Bile acids as regulators of hepatic lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Nuclear receptors as new perspective for the management of liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Farnesoid X receptor is essential for normal glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Pathophysiology guided treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

A G protein-coupled receptor responsive to bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Identification of membrane-type receptor for bile acids (M-BAR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Health implications of high dietary omega-6 polyunsaturated Fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

A lipidomic analysis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

The plasma lipidomic signature of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

Abnormal Plasma Microparticles Impair Vasoconstrictor Responses in Patients With Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

How different is the dietary pattern in non-alcoholic steatohepatitis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.789502

10.1517/14728222.2013.789502

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vlltrt5m55gyrlxjxydm5zlwk4

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_vlltrt5m55gyrlxjxydm5zlwk4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vlltrt5m55gyrlxjxydm5zlwk4

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/vlltrt5m55gyrlxjxydm5zlwk4